Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Cervical Cancer

  Free Subscription


01.04.2024

2 Abdom Radiol (NY)
1 ACS Appl Mater Interfaces
2 Adv Sci (Weinh)
1 Anticancer Res
4 Asian Pac J Cancer Prev
1 Biomed Res Int
2 BMC Cancer
1 BMC Infect Dis
1 BMC Womens Health
5 Brachytherapy
2 Cancer
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Treat Res Commun
3 Cancers (Basel)
1 Cell Biochem Biophys
1 Clin Appl Thromb Hemost
1 Crit Rev Oncol Hematol
2 Cureus
1 Diagnostics (Basel)
1 Discov Oncol
1 Environ Mol Mutagen
1 Eur J Cancer Prev
1 Expert Rev Anticancer Ther
1 Front Biosci (Landmark Ed)
3 Front Cell Infect Microbiol
2 Front Immunol
2 Front Oncol
1 Genes (Basel)
1 Gynecol Oncol
1 Gynecol Oncol Rep
1 Harm Reduct J
2 Int J Clin Oncol
2 Int J Environ Res Public Health
1 Int J Mol Sci
1 Int J Womens Health
1 Ir J Med Sci
1 J Appl Clin Med Phys
1 J Biophotonics
1 J Cell Mol Med
1 J Educ Health Promot
2 J Gynecol Oncol
1 J Infect Public Health
1 J Interprof Care
3 J Low Genit Tract Dis
1 J Med Microbiol
1 J Med Virol
1 J Nucl Med
1 J Radiat Res
2 Lancet
1 Life (Basel)
1 Matern Child Health J
1 Med Oncol
2 Medicina (Kaunas)
1 MethodsX
1 O G Open
1 Obstet Gynecol
1 Obstet Gynecol Sci
2 Pan Afr Med J
1 Pharmaceuticals (Basel)
1 Photodiagnosis Photodyn Ther
1 Phys Med Biol
1 Postepy Dermatol Alergol
1 Prev Med Rep
1 Qual Life Res
1 Reprod Health
1 Reprod Sci
1 Rom J Morphol Embryol
1 S Afr Med J
1 Virology
1 Viruses
1 World J Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Abdom Radiol (NY)

  1. ZHENG X, Shen F, Chen W, Ren W, et al
    Integrated pretreatment diffusion kurtosis imaging and serum squamous cell carcinoma antigen levels: a biomarker strategy for early assessment of radiotherapy outcomes in cervical cancer.
    Abdom Radiol (NY). 2024 Mar 27. doi: 10.1007/s00261-024-04270.
    PubMed         Abstract available

  2. ZHANG Y, Hu Y, Zhao S, Xu S, et al
    Validation of the 2018 FIGO staging system for stage IIIC cervical cancer by determining the metabolic and radiomic heterogeneity of primary tumors based on (18)F-FDG PET/CT.
    Abdom Radiol (NY). 2024 Mar 25. doi: 10.1007/s00261-024-04226.
    PubMed         Abstract available


    ACS Appl Mater Interfaces

  3. GOSECKA M, Gosecki M, Ziemczonek P, Urbaniak M, et al
    Selective Anticervical Cancer Injectable and Self-Healable Hydrogel Platforms Constructed of Drug-Loaded Cross-Linkable Unimolecular Micelles in a Single and Combination Therapy.
    ACS Appl Mater Interfaces. 2024;16:14605-14625.
    PubMed         Abstract available


    Adv Sci (Weinh)

  4. YUAN L, Jiang H, Jia Y, Liao Y, et al
    Fatty Acid Oxidation Supports Lymph Node Metastasis of Cervical Cancer via Acetyl-CoA-Mediated Stemness.
    Adv Sci (Weinh). 2024 Mar 23:e2308422. doi: 10.1002/advs.202308422.
    PubMed         Abstract available

  5. HU B, Wang R, Wu D, Long R, et al
    A Promising New Model: Establishment of Patient-Derived Organoid Models Covering HPV-Related Cervical Pre-Cancerous Lesions and Their Cancers.
    Adv Sci (Weinh). 2024;11:e2302340.
    PubMed         Abstract available


    Anticancer Res

  6. AOSHIKA T, Noda SE, Abe T, Kumazaki YU, et al
    Results of Definitive (Chemo)radiotherapy Using Computed Tomography-based Brachytherapy for Cervical Cancer.
    Anticancer Res. 2024;44:1583-1589.
    PubMed         Abstract available


    Asian Pac J Cancer Prev

  7. CHANGADE JV, Thanvi H, Raut C, Chavan M, et al
    In vitro Evaluation of Anti-Cancer Potential of Different Solvent Extracts Derived from Clerodendrum Infortunatum Linn against Cervical Cancer.
    Asian Pac J Cancer Prev. 2024;25:1065-1075.
    PubMed         Abstract available

  8. SHAMSI U, Zahid F, Abdul Jabbar AB, Musharraf MD, et al
    Human Papillomavirus Vaccine Awareness and Acceptability for Primary Prevention of Cervical Cancer in Pakistan: A Cross-Sectional Study.
    Asian Pac J Cancer Prev. 2024;25:813-820.
    PubMed         Abstract available

  9. PAL D, Sahoo BK, Taywade M, Maji S, et al
    Evidence of Knowledge, Attitude, and Practice Regarding Human Papilloma Virus Vaccination at the Community Level in India: A Systematic Review and Meta-analysis.
    Asian Pac J Cancer Prev. 2024;25:793-800.
    PubMed         Abstract available

  10. PATIL-TAKBHATE BR
    Cervical Cancer Screening Revolution: Advancements with Confocal Endomicroscopy.
    Asian Pac J Cancer Prev. 2024;25:723-724.
    PubMed        


    Biomed Res Int

  11. INTERNATIONAL BR
    Retracted: LINC00707 Promotes Cell Proliferation in Cervical Cancer via the miR-374c-5p/SDC4 Axis.
    Biomed Res Int. 2024;2024:9769120.
    PubMed         Abstract available


    BMC Cancer

  12. NAKIGOZI H, Ategyeka PM, Nabadda S, Ndejjo R, et al
    Positivity rates, trends and experiences of health workers on human papillomavirus screened using genexpert in Uganda: a three-year retrospective cohort study.
    BMC Cancer. 2024;24:375.
    PubMed         Abstract available

  13. LI X, Zhao Y, Xiang F, Zhang X, et al
    Evaluation of the diagnostic performance of colposcopy in the detection of cervical high-grade squamous intraepithelial lesions among women with transformation zone type 3.
    BMC Cancer. 2024;24:381.
    PubMed         Abstract available


    BMC Infect Dis

  14. AKAKPO PK, Imbeah EG, Ulzen-Appiah K, Darkwa-Abrahams A, et al
    The distribution of hrHPV genotypes among cervical cancer cases diagnosed across Ghana: a cross-sectional study.
    BMC Infect Dis. 2024;24:356.
    PubMed         Abstract available


    BMC Womens Health

  15. LALANDE E, Clarke H, Undurraga M, Nguyen VQH, et al
    Knowledge of cytology results affects the performance of colposcopy: a crossover study.
    BMC Womens Health. 2024;24:189.
    PubMed         Abstract available


    Brachytherapy

  16. ROMANO KD, Petroni G, Ward K, Zheng W, et al
    A randomized trial evaluating a novel hydrogel packing system compared to standard packing during image-guided high-dose rate brachytherapy boost for cervical cancer.
    Brachytherapy. 2024 Mar 21:S1538-4721(24)00035.
    PubMed         Abstract available

  17. PARIKH S, Zhang Y, Sherwani Z, Kumar R, et al
    Impact of the COVID-19 pandemic on brachytherapy and cancer patient outcomes: A systematic review.
    Brachytherapy. 2024;23:141-148.
    PubMed         Abstract available

  18. OWRANGI A, Medrano A, Gao Y, Kazemifar S, et al
    Definitive radiation for advanced cervix cancer is not associated with vaginal shortening-a prospective vaginal length and dose correlation.
    Brachytherapy. 2024;23:136-140.
    PubMed         Abstract available

  19. MANZAR GS, Alam MBE, Lynn EJ, Karpinets TV, et al
    Exploratory analysis of the cervix tumoral HPV antigen-specific T-cell repertoire during chemoradiation and after brachytherapy.
    Brachytherapy. 2024;23:123-135.
    PubMed         Abstract available

  20. TAKATSU J, Murakami N, Muramoto Y, Karino T, et al
    Safe dose escalation and reduction of the fraction number of uterine cervical brachytherapy using a gel spacer in the rectovaginal and vesicouterine septum: A planning study.
    Brachytherapy. 2024;23:115-122.
    PubMed         Abstract available


    Cancer

  21. MEGHANI K, Puri P, Bazzett-Matabele L, Vuylsteke P, et al
    Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana.
    Cancer. 2024 Mar 26. doi: 10.1002/cncr.35289.
    PubMed         Abstract available

  22. LEE H, Baeker Bispo J, Pal Choudhury P, Wiese D, et al
    Factors contributing to differences in cervical cancer screening in rural and urban community health centers.
    Cancer. 2024 Mar 25. doi: 10.1002/cncr.35265.
    PubMed         Abstract available


    Cancer Epidemiol Biomarkers Prev

  23. KROON KR, Bogaards JA, Heideman DA, Meijer CJ, et al
    Colposcopy referral and CIN3+ risk of human papillomavirus genotyping strategies in cervical cancer screening.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed         Abstract available


    Cancer Treat Res Commun

  24. TANIM MTH, Nath SD, Khan SF, Khan A, et al
    Transcriptomes of cervical cancer provide novel insights into dysregulated pathways, potential therapeutic targets, and repurposed drugs.
    Cancer Treat Res Commun. 2024;39:100808.
    PubMed         Abstract available


    Cancers (Basel)

  25. MOREAU M, Keno LS, China D, Mao S, et al
    Investigating the Use of a Liquid Immunogenic Fiducial Eluter Biomaterial in Cervical Cancer Treatment.
    Cancers (Basel). 2024;16:1212.
    PubMed         Abstract available

  26. PHILLIPS V, Franco Montoya D, Adams EK
    Evaluation of the Cost-Effectiveness of Evidence-Based Interventions to Increase Female Breast and Cervical Cancer Screens: A Systematic Review.
    Cancers (Basel). 2024;16:1134.
    PubMed         Abstract available

  27. BIANCHI T, Grassi T, Di Martino G, Negri S, et al
    Low-Volume Metastases in Cervical Cancer: Does Size Matter?
    Cancers (Basel). 2024;16:1107.
    PubMed         Abstract available


    Cell Biochem Biophys

  28. TANG XH, Zhao TN, Guo L, Liu XY, et al
    Cell-Cycle-related Protein Centromere Protein F Deficiency Inhibits Cervical Cancer Cell Growth by Inducing Ferroptosis Via Nrf2 Inactivation.
    Cell Biochem Biophys. 2024 Mar 27. doi: 10.1007/s12013-024-01251.
    PubMed         Abstract available


    Clin Appl Thromb Hemost

  29. CHENG S, Gao H, Li Y, Shi X, et al
    Analysis of Risk Factors of Postoperative Lower Extremity Deep Venous Thrombosis in Patients With Cervical Cancer.
    Clin Appl Thromb Hemost. 2024;30:10760296241240747.
    PubMed         Abstract available


    Crit Rev Oncol Hematol

  30. SNIADECKI M, Guani B, Jaworek P, Klasa-Mazurkiewicz D, et al
    Tertiary prevention strategies for micrometastatic lymph node cervical cancer: A systematic review and a prototype of an adapted model of care.
    Crit Rev Oncol Hematol. 2024 Mar 23:104329.
    PubMed         Abstract available


    Cureus

  31. FADL J, Aljuhani RA, Albog YH, Khraisat AF, et al
    Role of microRNA in Sex Steroid Hormones Signaling and Its Effect in Regulation of Endometrial, Ovarian, and Cervical Cancer: A Literature Review.
    Cureus. 2024;16:e54773.
    PubMed         Abstract available

  32. ZHANG N, Guo MF
    Granulocyte-Macrophage Colony-Stimulating Factor in Combination With Chemoradiation for Recurrent or Metastatic Cervical Cancer.
    Cureus. 2024;16:e54573.
    PubMed         Abstract available


    Diagnostics (Basel)

  33. KAYA TERZI N, Yulek O
    Assessment of Cervicovaginal Smear and HPV DNA Co-Test for Cervical Cancer Screening: Implications for Diagnosis and Follow-Up Strategies.
    Diagnostics (Basel). 2024;14:611.
    PubMed         Abstract available


    Discov Oncol

  34. YAN K, Hu C, Cheng Y, Zheng L, et al
    Circ_0020460 drives tumorigenesis in cervical cancer through miR-485-3p sponging.
    Discov Oncol. 2024;15:88.
    PubMed         Abstract available


    Environ Mol Mutagen

  35. PEREIRA IOA, Silva NNT, Lima AA, da Silva GN, et al
    Qualitative and quantitative changes in mitochondrial DNA associated with cervical cancer: A comprehensive review.
    Environ Mol Mutagen. 2024 Mar 24. doi: 10.1002/em.22591.
    PubMed         Abstract available


    Eur J Cancer Prev

  36. DOMBROWSKI C, Bourgain C, Ma Y, Meiwald A, et al
    An economic evaluation of two cervical screening algorithms in Belgium: HR-HPV primary compared to HR-HPV and liquid-based cytology co-testing.
    Eur J Cancer Prev. 2024;33:262-270.
    PubMed         Abstract available


    Expert Rev Anticancer Ther

  37. CAROBELI LR, Santos ABC, Martins LBM, Damke E, et al
    Recent advances in photodynamic therapy combined with chemotherapy for cervical cancer: a systematic review.
    Expert Rev Anticancer Ther. 2024 Mar 28. doi: 10.1080/14737140.2024.2337259.
    PubMed         Abstract available


    Front Biosci (Landmark Ed)

  38. LI C, Li Q, Li L, Sun S, et al
    The Prognostic and Immune Significance of BZW2 in Pan-Cancer and its Relationship with Proliferation and Apoptosis of Cervical Cancer.
    Front Biosci (Landmark Ed). 2024;29:97.
    PubMed         Abstract available


    Front Cell Infect Microbiol

  39. LOONEN AJM, Verhagen F, Luijten-de Vrije I, Lentjes-Beer M, et al
    Vaginal dysbiosis seems associated with hrHPV infection in women attending the Dutch Cervical Cancer Screening Program.
    Front Cell Infect Microbiol. 2024;14:1330844.
    PubMed         Abstract available

  40. GONCALVES-NOBRE JG, Matos A, Carreira M, Santos AC, et al
    The interplay between HPV, other Sexually Transmissible Infections and genital microbiome on cervical microenvironment (MicroCervixHPV study).
    Front Cell Infect Microbiol. 2024;13:1251913.
    PubMed         Abstract available

  41. ALBANO C, Biolatti M, Mazibrada J, Pasquero S, et al
    PAD-mediated citrullination is a novel candidate diagnostic marker and druggable target for HPV-associated cervical cancer.
    Front Cell Infect Microbiol. 2024;14:1359367.
    PubMed         Abstract available


    Front Immunol

  42. LI T, Zhang W, Niu M, Wu Y, et al
    STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance.
    Front Immunol. 2024;15:1342647.
    PubMed         Abstract available

  43. KOUSAR K, Naseer F, Abduh MS, Anjum S, et al
    Corrigendum: CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach.
    Front Immunol. 2024;15:1391710.
    PubMed         Abstract available


    Front Oncol

  44. ZHAO W, Li Q, Wen S, Li Y, et al
    Novel biomarkers of inflammation-associated immunity in cervical cancer.
    Front Oncol. 2024;14:1351736.
    PubMed         Abstract available

  45. BELLOTTI JA, Gutierres IG, Furtado YL, Patury P, et al
    Surgical, oncologic, and obstetric outcomes of radical trachelectomy in early-stage cervical cancer: results from a retrospective cohort study at Brazil National Cancer Institute.
    Front Oncol. 2024;14:1267625.
    PubMed         Abstract available


    Genes (Basel)

  46. ALMOROX L, Antequera L, Rojas I, Herrera LJ, et al
    Gene Expression Analysis for Uterine Cervix and Corpus Cancer Characterization.
    Genes (Basel). 2024;15:312.
    PubMed         Abstract available


    Gynecol Oncol

  47. CHOI KH, Lee HC, Kim YS, Park W, et al
    Diagnostic assessments and treatment results of well-differentiated gastric-type adenocarcinoma of the uterine cervix (Adenoma malignum): A multicenter retrospective analysis of KROG 22-03 study.
    Gynecol Oncol. 2024;182:45-50.
    PubMed         Abstract available


    Gynecol Oncol Rep

  48. BABAYAN LM, Bouts C, Guntupalli S, Marjon NA, et al
    Exploring tisotumab vedotin in recurrent cervical cancer: A case series including an HPV-independent gastric type adenocarcinoma.
    Gynecol Oncol Rep. 2024;52:101356.
    PubMed         Abstract available


    Harm Reduct J

  49. HINKES S, Ciraldo K, Kobetz E, Bartholomew TS, et al
    Opportunities for cancer prevention at syringe services programs: acceptability of HPV self-sampling and vaccination among people who inject drugs.
    Harm Reduct J. 2024;21:70.
    PubMed         Abstract available


    Int J Clin Oncol

  50. KANG HB, Kim SH, Lee JH, Lee HC, et al
    MRI-based volumetric tumor parameters before and during chemoradiation predict tumor recurrence and patient survival in locally advanced cervical cancer: a subgroup analysis of a phase II prospective trial.
    Int J Clin Oncol. 2024 Mar 26. doi: 10.1007/s10147-024-02490.
    PubMed         Abstract available

  51. NAKAI H, Higashi T, Kakuwa T, Matsumura N, et al
    Trends in gynecologic cancer in Japan: incidence from 1980 to 2019 and mortality from 1981 to 2021.
    Int J Clin Oncol. 2024;29:363-371.
    PubMed         Abstract available


    Int J Environ Res Public Health

  52. LOCKWOOD L, Ju X, Sethi S, Hedges J, et al
    Knowledge and Awareness of HPV, the HPV Vaccine and Cancer-Related HPV Types among Indigenous Australians.
    Int J Environ Res Public Health. 2024;21:307.
    PubMed         Abstract available

  53. COSTA AS, Baracat EC, Junior JMS, Sorpreso ICE, et al
    Pap Smear Cancer Coverage in Brazilian Capitals including the Pandemic Period Caused by the SARS-CoV-2 Virus: Ecological Study.
    Int J Environ Res Public Health. 2024;21:303.
    PubMed         Abstract available


    Int J Mol Sci

  54. LEE WT, Wu PY, Cheng YM, Huang YF, et al
    Tissue Inhibitor of Metalloproteinase 3: Unravelling Its Biological Function and Significance in Oncology.
    Int J Mol Sci. 2024;25:3191.
    PubMed         Abstract available


    Int J Womens Health

  55. BALUWA PC, Moyo RC, Baluwa MA, Nyirenda L, et al
    Barriers Associated with Adherence to Cervical Cancer Screening Among Women Living with HIV in Nkhatabay District, Malawi: A Mixed-Methods Study.
    Int J Womens Health. 2024;16:491-507.
    PubMed         Abstract available


    Ir J Med Sci

  56. ROURKE M, Fitzpatrick P, Popoola O, Boms R, et al
    The effect of HPV vaccination on the rate of high-grade cytology in 25-year-old women attending cervical screening in Ireland.
    Ir J Med Sci. 2024;193:665-668.
    PubMed         Abstract available


    J Appl Clin Med Phys

  57. WANG X, Chang Y, Pei X, Xu XG, et al
    A prior-information-based automatic segmentation method for the clinical target volume in adaptive radiotherapy of cervical cancer.
    J Appl Clin Med Phys. 2024 Mar 28:e14350. doi: 10.1002/acm2.14350.
    PubMed         Abstract available


    J Biophotonics

  58. DEO BS, Sah AN, Shukla S, Pandey K, et al
    Cervical pre-cancer classification using entropic features and CNN: In vivo validation with a handheld fluorescence probe.
    J Biophotonics. 2024;17:e202300363.
    PubMed         Abstract available


    J Cell Mol Med

  59. YING L, Kong L, Qiu X, Cheng A, et al
    A novel mitochondria-related core gene signature to predict the prognosis and evaluate tumour microenvironment in CESC single-cell validation.
    J Cell Mol Med. 2024;28:e18265.
    PubMed         Abstract available


    J Educ Health Promot

  60. GHASEMI-GUJANI M, Savabi-Esfahani M, Noroozi M, Satari M, et al
    Development of mobile application for cervical cancer screening in women: Protocol of a multi-phase study.
    J Educ Health Promot. 2024;13:5.
    PubMed         Abstract available


    J Gynecol Oncol

  61. LIU Y, Xin W, Wang P, Ji M, et al
    Intraoperative frozen section pathology of vaginal margin in radical hysterectomy on the prognosis and quality of life for patients with IB2-IIA2 cervical cancer: study protocol for a multicenter randomized controlled trial.
    J Gynecol Oncol. 2024 Mar 11. doi: 10.3802/jgo.2024.
    PubMed         Abstract available

  62. CHO EH, Park MS, Woo HY, Park H, et al
    Evaluation of clinical usefulness of HPV-16 and HPV-18 genotyping for cervical cancer screening.
    J Gynecol Oncol. 2024 Mar 15. doi: 10.3802/jgo.2024.
    PubMed         Abstract available


    J Infect Public Health

  63. ALHERZ FA, Alamri AA, Aljbreen A, Alwallan N, et al
    Knowledge of cervical cancer, human papillomavirus (HPV), and acceptance of the HPV vaccine among parents of daughters in Riyadh, Saudi Arabia.
    J Infect Public Health. 2024;17:789-794.
    PubMed         Abstract available


    J Interprof Care

  64. GUAN P, Han X, Li D, Liao B, et al
    Effect of nurse-physician collaboration on the incidence of complications, negative emotions and quality of life in cervical cancer patients: a randomized controlled study.
    J Interprof Care. 2024 Mar 25:1-9. doi: 10.1080/13561820.2024.2327621.
    PubMed         Abstract available


    J Low Genit Tract Dis

  65. SOEGAARD-ANDERSEN E, Frandsen AP, Sandahl P
    Adenocarcinoma In Situ of the Uterine Cervix (AIS) Treated by Loop Electrosurgical Excision Procedure Strategy: An Observational Study.
    J Low Genit Tract Dis. 2024;28:149-152.
    PubMed         Abstract available

  66. CLARKE MA, Wentzensen N, Perkins RB, Garcia F, et al
    Recommendations for Use of p16/Ki67 Dual Stain for Management of Individuals Testing Positive for Human Papillomavirus.
    J Low Genit Tract Dis. 2024;28:124-130.
    PubMed         Abstract available

  67. GRACA J, Preti M, Pollano B, Vieira-Baptista P, et al
    Performance of Different Follow-Up Strategies and Genotype-Based Recurrence Risk After Treatment of Cervical High-Grade Squamous Intraepithelial Lesion.
    J Low Genit Tract Dis. 2024;28:131-136.
    PubMed         Abstract available


    J Med Microbiol

  68. KAMBLE A, Naik S, Talathi M, Jadhav D, et al
    Exploring the diversity of vaginal microbiota between healthy women and cervical cancer patients in India.
    J Med Microbiol. 2024;73.
    PubMed         Abstract available


    J Med Virol

  69. KIM M, Kim E
    Effective vaccination strategies for human papillomavirus (HPV) infection and cervical cancer based on the mathematical model with a stochastic process.
    J Med Virol. 2024;96:e29558.
    PubMed         Abstract available


    J Nucl Med

  70. COLLARINO A, Feudo V, Pasciuto T, Florit A, et al
    Is PET Radiomics Useful to Predict Pathologic Tumor Response and Prognosis in Locally Advanced Cervical Cancer?
    J Nucl Med. 2024 Mar 28:jnumed.123.267044. doi: 10.2967/jnumed.123.267044.
    PubMed         Abstract available


    J Radiat Res

  71. IKUSHIMA H, Ii N, Noda SE, Masui K, et al
    Patterns of care for brachytherapy in Japan.
    J Radiat Res. 2024;65:168-176.
    PubMed         Abstract available


    Lancet

  72. TEWARI KS, Monk BJ
    Immunotherapy plus chemoradiotherapy in cervical cancer management.
    Lancet. 2024 Mar 20:S0140-6736(24)00468-9. doi: 10.1016/S0140-6736(24)00468.
    PubMed        

  73. LORUSSO D, Xiang Y, Hasegawa K, Scambia G, et al
    Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.
    Lancet. 2024 Mar 20:S0140-6736(24)00317-9. doi: 10.1016/S0140-6736(24)00317.
    PubMed         Abstract available


    Life (Basel)

  74. JUNG L, Klamminger GG, Bier B, Eltze E, et al
    From Satirical Poems and Invisible Poisons to Radical Surgery and Organized Cervical Cancer Screening-A Historical Outline of Cervical Carcinoma and Its Relation to HPV Infection.
    Life (Basel). 2024;14:307.
    PubMed         Abstract available


    Matern Child Health J

  75. WANG S, Ren W, Zhang B, Chen M, et al
    Knowledge, Attitude, and Uptake of Human Papillomavirus (HPV) Vaccination among Chinese Female Adults: A National Cross-sectional Web-Based Survey Based on a Large E-commerce Platform.
    Matern Child Health J. 2024;28:746-757.
    PubMed         Abstract available


    Med Oncol

  76. KRISHNAMOORTHY S, Sabanayagam R, Periyasamy L, Muruganantham B, et al
    Plumbagin as a preferential lead molecule to combat EGFR-driven matrix abundance and migration of cervical carcinoma cells.
    Med Oncol. 2024;41:89.
    PubMed         Abstract available


    Medicina (Kaunas)

  77. VITKAUSKAITE A, Urboniene D, Celiesiute J, Jariene K, et al
    Expression of Inflammation Depending on the Stage of Cervical Cancer.
    Medicina (Kaunas). 2024;60:349.
    PubMed         Abstract available

  78. SCHETTINO MT, Preti EP, Vietri V, Agrillo N, et al
    The Role of beta1 Integrin/CD29 as a Potential Prognostic Factor for the Risk of Progression to Cervical Carcinoma in HPV-Associated Lesions.
    Medicina (Kaunas). 2024;60:364.
    PubMed         Abstract available


    MethodsX

  79. CHAUHAN R, Goel A, Alankar B, Kaur H, et al
    Predictive modeling and web-based tool for cervical cancer risk assessment: A comparative study of machine learning models.
    MethodsX. 2024;12:102653.
    PubMed         Abstract available


    O G Open

  80. HARPER DM, Yu TM, Fendrick AM
    Lives Saved Through Increasing Adherence to Follow-Up After Abnormal Cervical Cancer Screening Results.
    O G Open. 2024;1:e001.
    PubMed         Abstract available


    Obstet Gynecol

  81. TROISI R, Bertrand K, Hatch EE, Strohsnitter WC, et al
    An Update on Prenatal Diethylstilbestrol Exposure and High-Grade Squamous Intraepithelial Lesions of the Lower Genital Tract.
    Obstet Gynecol. 2024;143:603-606.
    PubMed         Abstract available


    Obstet Gynecol Sci

  82. WONGPRATATE M, Bumrungthai S
    Cervical cancer in Thailand: 2023 update.
    Obstet Gynecol Sci. 2024 Mar 25. doi: 10.5468/ogs.23277.
    PubMed         Abstract available


    Pan Afr Med J

  83. AMORHA KC, Ozota GO, Ndunwere MO, Anyaji UL, et al
    Knowledge, attitudes, and practices of adolescent girls regarding cervical cancer: a cross-sectional study in Enugu State, Nigeria.
    Pan Afr Med J. 2024;47:17.
    PubMed         Abstract available

  84. ZRAIDI M, Ibriz M
    [The timeline of the screening and treatment strategy of intraepithelial neoplasia of the uterine cervix adopted in Morocco].
    Pan Afr Med J. 2024;47:13.
    PubMed         Abstract available


    Pharmaceuticals (Basel)

  85. GARCIA-ROCHA R, Monroy-Garcia A, Vazquez-Cruz AL, Marin-Aquino LA, et al
    Adenosine Increases the Immunosuppressive Capacity of Cervical Cancer Cells by Increasing PD-L1 Expression and TGF-beta Production through Its Interaction with A(2A)R/A(2B)R.
    Pharmaceuticals (Basel). 2024;17:397.
    PubMed         Abstract available


    Photodiagnosis Photodyn Ther

  86. GILYADOVA AV, Ishchenko AA, Samoilova SV, Shiryaev AA, et al
    Comparative study of treatment efficacy in severe intraepithelial squamous cell lesions and preinvasive cervical cancer by conization and chlorin e6-mediated fluorescence-assisted systemic photodynamic therapy.
    Photodiagnosis Photodyn Ther. 2024;46:104060.
    PubMed         Abstract available


    Phys Med Biol

  87. GAO Y, Gonzalez Y, Nwachukwu C, Albuquerque K, et al
    Predicting treatment plan approval probability for high-dose-rate brachytherapy of cervical cancer using adversarial deep learning.
    Phys Med Biol. 2024 Mar 27. doi: 10.1088/1361-6560/ad3880.
    PubMed         Abstract available


    Postepy Dermatol Alergol

  88. POPOVIC A, Bojic MD, Bojic M, Vukmirovic F, et al
    Cutaneous metastases of cervical cancer: a rare entity and possible mechanisms of dissemination.
    Postepy Dermatol Alergol. 2024;41:136-138.
    PubMed        


    Prev Med Rep

  89. BURDIER FR, Waheed DE, Nedjai B, Steenbergen RDM, et al
    DNA methylation as a triage tool for cervical cancer screening - A meeting report.
    Prev Med Rep. 2024;41:102678.
    PubMed         Abstract available


    Qual Life Res

  90. TAAVELA K, Eriksson T, Huhtala H, Bly A, et al
    The quality of life of frequently vs. infrequently screened HPV vaccinated women.
    Qual Life Res. 2024;33:941-949.
    PubMed         Abstract available


    Reprod Health

  91. ELISSA N, Charbel H, Marly A, Ingrid N, et al
    Knowledge and perception of HPV vaccination among Lebanese mothers of children between nine and 17 years old.
    Reprod Health. 2024;21:40.
    PubMed         Abstract available


    Reprod Sci

  92. DUTTA P, Pal D, Sultana F, Mandal RK, et al
    Down-regulation of FA-BRCA Pathway in Cervical Carcinoma Gradually Reversed During the Development of Chemo-tolerance: Clinical Implications.
    Reprod Sci. 2024;31:1122-1138.
    PubMed         Abstract available


    Rom J Morphol Embryol

  93. VOIDAZAN TS, Budianu MA, Cotoi OS, Turdean SG, et al
    The importance of combined HPV and CINtec(R) PLUS genotyping testing for p16 in women with cervical squamous cell carcinoma.
    Rom J Morphol Embryol. 2024;65:99-105.
    PubMed         Abstract available


    S Afr Med J

  94. OOKO F
    Ensuring access to palliative care for cervical cancer patients.
    S Afr Med J. 2023;114:3-4.
    PubMed        


    Virology

  95. LE VN, Le VNB, Hoang XS, Le VD, et al
    Distribution of human papillomavirus among Vietnamese women with cervical cancer and unusual genetic variability of HPV16.
    Virology. 2024;594:110058.
    PubMed         Abstract available


    Viruses

  96. HERNANDEZ-SILVA CD, Ramirez de Arellano A, Pereira-Suarez AL, Ramirez-Lopez IG, et al
    HPV and Cervical Cancer: Molecular and Immunological Aspects, Epidemiology and Effect of Vaccination in Latin American Women.
    Viruses. 2024;16:327.
    PubMed         Abstract available


    World J Oncol

  97. WARLI SM, Tala MRZ, Wijaya WS
    Predictive Factors of Successful Double J Stent Insertion Among Advanced Cervical Cancer Patients.
    World J Oncol. 2024;15:239-245.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.